Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study

Table 2 Intima-media thickness, plaque score, and pulse wave velocity changes at Week 156

	Abatacept (AY + AO)	csDMARDs (CY + CO)	P value
Mean intima-media thickness of common carotid artery
Left	0.022 ± 0.115	0.031 ± 0.116	0.6525
Right	0.019 ± 0.125	0.034 ± 0.126	0.5163
Max intima-media thickness of common carotid artery, bulbus, bifurcation, and internal carotid artery
Left	0.008 ± 0.149	0.020 ± 0.215	0.7021
Right	0.003 ± 0.208	0.018 ± 0.203	0.6817
Plaque score	-0.446 ± 1.662	0.227 ± 1.915	0.0544
Pulse wave velocity
Left	38.9 ± 384.5	73.0 ± 357.5	0.6092
Right	60.1 ± 242.1	32.3 ± 196.8	0.4868

Results are reported as change of the measured value compared with the baseline value. Abbreviations: AO: older patients taking abatacept; AY: younger patients taking abatacept; CO: older patients taking conventional synthetic disease-modifying antirheumatic drugs; csDMARDs: conventional synthetic disease-modifying antirheumatic drugs; CY: younger patients taking conventional synthetic disease-modifying antirheumatic drugs

ISSN: 1478-6362